Drug regimens now offer more potent, less toxic and more durable choices in the treatment of HIV disease than ever before. This has led to a need to consider the convenient, sequential use of active ...

Genotyping tests were developed to attenuate the impact of viral resistance. Information about the efficacy in genotype base antiretroviral therapy in children is rare and even more in low- and middle ...

Please provide your email address to receive an email when new articles are posted on . Therapeutic options for adults with heavily treatment-experienced (HTE) HIV-1 infection and virologic failure ...

Their scientific methods may have been quite different, but their conclusions were not. In asking whether drug resistance could be a problem if antiretroviral (ARV) drugs become a mainstay for HIV ...

(HealthDay News) — Resistance to antiretroviral therapy (ART) is threatening the recent gains of treatment in the rate of new HIV infections, according to a perspective article published online Oct.

Globally, in 2020, 38 million people were living with HIV with an additional 1.5 million newly infected. During this period, 73% of those living with HIV were accessing antiretroviral therapy (WHO HIV ...

HIV treatment has been improved and simplified significantly over the years, yet a small fraction of people living with HIV ...

During HIV treatment resistance mutations of the virus to antiretroviral drugs may occur and the treatment regimen become less effective. In the present study the authors compared the ...

Only a limited number of surveillance drug-resistance mutations are responsible for most instances of non-nucleoside reverse transcriptase inhibitor- and nucleoside reverse transcriptase ...

HIV drug resistance is closely related to viral failure and poor prognosis in drug-experienced patients. [64,65,66] Several cohort studies of patients taking ARVs who were stratified by CD4 cell count ...